IRIS

Imatinib mesylate therapy in chronic myeloid leukemia patients in stable complete cytogenic response after interferon-alpha results in a very high complete molecular response rate / Alimena, G; Breccia, M; Luciano, L; Quarantelli, F; Diverio, D; Izzo, Barbara; DE ANGELIS, B; Mancini, M; Latagliata, R; Carmosino, I; Nanni, M; Picardi, Marco; Rotoli, B; Mandelli, F; Pane, Fabrizio. - In: LEUKEMIA RESEARCH. - ISSN 0145-2126. - STAMPA. - 32:2(2007), pp. 255-261.

Imatinib mesylate therapy in chronic myeloid leukemia patients in stable complete cytogenic response after interferon-alpha results in a very high complete molecular response rate

IZZO, BARBARA;PICARDI, MARCO;PANE, FABRIZIO
2007
2007
Imatinib mesylate therapy in chronic myeloid leukemia patients in stable complete cytogenic response after interferon-alpha results in a very high complete molecular response rate / Alimena, G; Breccia, M; Luciano, L; Quarantelli, F; Diverio, D; Izzo, Barbara; DE ANGELIS, B; Mancini, M; Latagliata, R; Carmosino, I; Nanni, M; Picardi, Marco; Rotoli, B; Mandelli, F; Pane, Fabrizio. - In: LEUKEMIA RESEARCH. - ISSN 0145-2126. - STAMPA. - 32:2(2007), pp. 255-261.
1.1 Articolo in rivista
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11588/203601
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 13
  • ???jsp.display-item.citation.isi??? 13
social impact